Literature DB >> 17435856

[Metabolic profile according to leptin levels in obese patients].

Alina C R Feitosa1, Márcio C Mancini, Cíntia Cercato, Sandra M Villares, Alfredo Halpern.   

Abstract

Increased body mass index and waist circumference are related to cardiovascular risk factors. Leptin is an adipocyte-produced hormone and regulates body weight. Leptin is directly related to body fat. To evaluate the relationship between leptin and metabolic profile in obese subjects, we studied 119 patients. Anthropometric, laboratory, body composition (by bioelectrical impedance) and co-morbidity data were collected. The analysis was performed in the female population (86.6%): average age: 42 +/- 13 years; hypertension, type 2 diabetes and grade III obesity were present in 61.9%, 20.2% and 58.3%, respectively. Leptin levels were positively related to insulin resistance (IR). HOMA-IR was related to metabolic abnormalities of IR. No differences were demonstrated between lipid profile, glycemia, body composition and tertiles of leptin corrected by fat weight. A significant difference in HOMA-IR was present when the 2nd and 3rd tertiles of leptin corrected by fat weight [3.4 (2.8-4.1) vs. 5.3 (4.1-6.5), p=0.011] were compared. In conclusion, leptin corrected by fat weight did not influence lipid profile and glycemia in moderate to severe obese women with similar percent body fat. Leptin should not be considered an independent factor affecting lipid metabolism.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17435856     DOI: 10.1590/s0004-27302007000100010

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  2 in total

1.  Congenital leptin deficiency: diagnosis and effects of leptin replacement therapy.

Authors:  Gilberto Paz-Filho; Claudio Mastronardi; Tuncay Delibasi; Ma-Li Wong; Julio Licinio
Journal:  Arq Bras Endocrinol Metabol       Date:  2010-11

2.  Leptin Concentrations in Non-Obese and Obese Non-Diabetes Nigerian-Africans.

Authors:  Obiageli Uzoamaka Agbogu-Ike; Dimie Ogoina; Geoffrey Chukwubuike Onyemelukwe
Journal:  Diabetes Metab Syndr Obes       Date:  2021-12-21       Impact factor: 3.168

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.